GLYPHAGO Trademark

Trademark Overview

On Thursday, August 14, 2025, a trademark application was filed for GLYPHAGO with the United States Patent and Trademark Office. The USPTO has given the GLYPHAGO trademark a serial number of 99336893. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, August 14, 2025. This trademark is owned by Seaport Therapeutics, Inc.. The GLYPHAGO trademark is filed in the Advertising, Business and Retail Services, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Technologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases

Commercialization, namely, commercial consultancy in the pharmaceutical and biotechnology fields

Research and development in the pharmaceutical and biotechnology fields; medical and scientific research in the field of clinical trials
glyphago

General Information

Serial Number99336893
Word MarkGLYPHAGO
Filing DateThursday, August 14, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, August 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesTechnologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases
Goods and ServicesCommercialization, namely, commercial consultancy in the pharmaceutical and biotechnology fields
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; medical and scientific research in the field of clinical trials

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, August 14, 2025
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 14, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 14, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSeaport Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Thursday, August 14, 2025NEW APPLICATION ENTERED
Thursday, August 14, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

glyphago diseases disorders pharmaceutical lymphatic namely fields research biotechnology metabolic genetic